BusStim-LLC-logo

Our Team of Experts

BusStim's leadership team and drug translational team of experts are former pharma executives from across the industry 


Clinical & Medical Professionals

Here are a few of our featured members from our Medical Professionals

Dereck D Amakye, MD FFPM

Oncologist

About Dereck

Giovanni Selvaggi, MD

Oncologist/Pulmonologist

About Giovanni

HONG LI, MD

Neurologist

About Hong

Leonard Sigal, MD

Rheumatologist / Immunologist

About Leonard


These physicians design cost-efficient and innovative clinical trials to create or achieve Proof of Concept (POC) in humans/clinical. They also design clinical and regulatory strategies to build investor’s confidence in their program. In many cases, these experts join our partner companies as Chief Medical Officer (CMO) to enhance their management team. They will lead the Clinical Drug Development Activities to bring in other members of BusStim’s clinical experts as needed.


Early Stage Development Team

Here are a few of our featured members from our Early Stage Development Team

Rimma L. Steinhertz, PhD, PMP

Oncology Program Leader

About Rimma

Doug MaeNeil, Ph.D.

Early Drug Discovery and Development

About Doug

Scott M. Wilhelm, Ph.D

Cancer Discovery Executive

About Scott

Louis Mylecraine, M.S., PhD

Toxicologist

About Louis

These fifteen to twenty experts join our companies as VP of preclinical development or chief scientific officer. They provide the following services:

• Identifying and creating the right studies to achieve Proof of Concept (POC) preclinical

 • CRO Selection & Management

• Pharmacology

• Toxicology

• CMC & formulation Services

• Project Management

• IND application preparation & submission

These scientists have proven experience in filling successful IND submissions.


Executive/ Entrepreneur in Residence Team


Here are a few of our featured members from our EIR Team

Larry Ellis Loss, PharmD, MBA

Senior Executive in Residence

About Larry

Scott Alpizar, Ph.D.

Evaluation Team Leader

About Scott

Brandon Hogstad, Ph.D.

Evaluation Team Leader

About Brandon

Frank Kondrad

Evaluation Team Leader

About Frank

Our executive/entrepreneur in residence team is made up of former Pharma Business Development & Commercialization executives and Biotech C-Level executives. These EIRs join our partner companies as Chief Executive Officer (CEO) or Chief Business Officer (CBO) to enhance their management team. In this capacity, the CEO will lead the fundraising and Pharma partnering effort, working with the BusStim’s partners utilizing our resources and collective investment/Pharma contacts. The CEO will also gain the confidence of the investors to lead the companies' fundraising.

Share by: